HOME >> BIOLOGY >> NEWS
Vitamin D deficiency and bowel diseases connected

Research with mice at Penn State has demonstrated a connection between vitamin D deficiency and two bowel diseases that occur in one out of every 1,000 people in North America and Europe.

Dr. Margherita T. Cantorna, assistant professor of nutrition and director of the research project, says "Our experiments show that vitamin D deficiency worsens the symptoms of Chron's disease and ulcerative colitis. Treatment with Vitamin D for as little as two weeks lessens the symptoms of these inflammatory bowel diseases in mice."

Cantorna detailed her research in a paper, "Vitamin D Deficiency Exacerbates Experimental Inflammatory Bowel Disease," presented today (April 18) at the Experimental Biology conference in San Diego, Calif. Her co-authors are Carey Munsick, a Penn State undergraduate, and Candace Bemiss, a Penn State master's degree candidate in nutrition. Their paper is the first in which researchers report demonstrating a connection between vitamin D deficiency and inflammatory bowel disease (IBD).

In her team's experiments, mice genetically engineered to spontaneously develop the symptoms of either Chron's disease or ulcerative colitis were also made vitamin D deficient at birth. The mice were then either maintained deficient or given vitamin D supplements in their food to bring them up to the normal level. The treated mice had less bowel inflammation than the untreated mice did. In addition, the mice that did not receive the supplements began to die at seven weeks of age and by nine weeks more than half were dead. In contrast none of the mice that received the supplements died during the experiment period.

"Vitamin D deficiency is more common in people who have inflammatory bowel disease. In addition, the anti-inflammatory drugs often used to treat IBD can cause bone loss as a side effect," Cantorna says. "Vitamin D taken in combination with these drugs may be able to reduce the effective dose of anti-inflammatory needed to tr
'"/>

Contact: Barbara Hale
bah@psu.edu
814-865-9481
Penn State
17-Apr-2000


Page: 1 2 3

Related biology news :

1. Vitamins do little to prevent recurrent stroke
2. Vitamin C may protect against ulcer-causing bacteria, study finds
3. Vitamin D analog found to boost radiation
4. As Vitamin B-6 levels go down, numbers of DNA strand breaks go up
5. UC Riverside biochemists develop technology to increase Vitamin C in plants
6. Vitamin D may be crucial in preventing colon cancer
7. Vitamin C transporter gene discovery in mice
8. Vitamin E and aspirin delay heart disease in mice even with high cholesterol levels
9. Rat genes increase Vitamin C in plants
10. Vitamin C produces gene-damaging compounds, test-tube study in Science reports
11. Penn study finds signs folic acid and Vitamin B12 may lessen some ill effects of SMA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... February 24, 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused ... Institute of Mental Health (NIMH) for the further advancement of the company’s 3-month olanzapine ... and is expected to deliver therapeutic levels of olanzapine for a period of 3 ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/23/2017)... 23, 2017 ... per share data, unaudited)Three Months Ended December 31,Twelve Months ... $         ...   89026%Aldurazyme Net Product Revenue ... Net Product Revenue  756025%297303(2)%Vimizim Net ...
Breaking Biology Technology:
Cached News: